Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 293
Selected: 0
NCT IDTitle
NCT01626092Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders
NCT00176865Stem Cell Transplant for Immunologic or Histiocytic Disorders
NCT02661035Allo HSCT Using RIC for Hematological Diseases
NCT03365661QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML
NCT00352118Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
NCT03297463Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma
NCT01385423Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)
NCT00617929Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
NCT01451502Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
NCT01593618Empowering Cancer Survivors Through Information Technology
NCT00176826T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
NCT01343368Preservation of Ovarian Function After Hematopoietic Cell Transplant
NCT06792825HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
NCT01652092Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
NCT04630769FT516 and IL2 With Enoblituzumab for Ovarian Cancer
NCT00095160Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors
NCT00622674Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
NCT00652899Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer
NCT03294304BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy
NCT00005987Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma
NCT01885897IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT
NCT04928950Charcoal in Lung Cancer Patients Undergoing TEMLA
NCT02046291Safety of Romiplostim (Nplate®) Following UCBT
NCT02042924Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies
NCT02227797MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients
NCT01581970Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer
NCT03125642Auto Stem Cell Transplant for Lymphoma Patients
NCT06693986Adenovirus (RGDCRAdCOX2F)
NCT00818649Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
NCT00176917Stem Cell Transplantation for Hurler
NCT00167167Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia
NCT00287911Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer
NCT00625092Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies
NCT03651037Physical Activity Platform to Improve Bone Health in Cancer Survivors
NCT04363346Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia
NCT01505569Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
NCT05973656Role of Acetaldehyde in the Development of Oral Cancer
NCT02948062Early Diagnosis Of Childhood Cerebral ALD
NCT06342986Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT00303667Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant
NCT02670837Study of Cellutome System for Treatment of Individual Lesions in EB Pts
NCT01099631IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread
NCT03383055CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig
NCT00619021Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
NCT00618696Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia
NCT01033552Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs
NCT01634217Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation
NCT00376519Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases
NCT06584929Rural Smoking Cessation
NCT02500472Investigation of Kava Effects on NNK Metabolism